PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched

2021 postponement will ensure positive business conditions and greater attendance

Amsterdam, 27 July 2020: CPhI Japan – organised by Informa Markets – announces that, following a detailed review with partners and key industry stakeholders and to ensure the health and safety of our community, the event will be postponed until April 14-16, 2021.

The event organiser’s move to the new dates will provide more time for the market to adapt and for a positive business environment to return, with greater easing of international travel restrictions likely by Spring 2021.

“We had been optimistic that the event could go ahead and we know how important it is for the pharma market in Japan to have a tailored platform to meet international customers and industry professionals. Meeting in person is an essential part of business in Japan. However, the decision to postpone reflects the reality that many companies and governments still have uncertain and ongoing travel restrictions in place. We are committed to ensuring CPhI Japan 2021 is well worth the wait and look forward to welcoming global pharma back to Japan. Thank you to all of our key stakeholders for their continued support” commented Christopher Eve, Senior Vice President, CPhI Japan at Informa Markets.

Informa Markets will continue to host the event at the Big Sight Exhibition Centre in Tokyo in April 2021 and is working on preparing a number of bespoke digital product offerings to help the market continue to meet, do business and exchange ideas later this year. Further details will be available shortly

“To facilitate our community in achieving their business goals, a suite of digital solutions will be launched to empower customer relations, meet new partners and undertake industry learnings” added Eve.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026